The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kroll Mark W since 2015.
This trader's CIK number is 1259254.
At the time of last reporting, Kroll Mark W was the Director of Haemonetics Corp. (stock ticker symbol HAE).
Also see all insider trading activities at Haemonetics Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | HAE | 1,400 | $98,784 | 0 | $0 | 0 | $0 |
| 2022 | HAE | 0 | $0 | 8,016 | $590,859 | 0 | $0 |
| 2021 | HAE | 0 | $0 | 11,813 | $650,896 | 10,353 | $367,562 |
| 2020 | HAE | 0 | $0 | 10,902 | $1,112,004 | 6,573 | $298,742 |
| 2018 | HAE | 0 | $0 | 17,825 | $1,669,032 | 15,314 | $542,982 |
| 2017 | HAE | 0 | $0 | 8,580 | $355,992 | 8,580 | $233,719 |
| 2015 | HAE | 0 | $0 | 11,328 | $507,483 | 11,328 | $331,117 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | AXON | 0 | $0 | 3,549 | $783,573 | 0 | $0 |
| 2022 | AXON | 0 | $0 | 3,159 | $324,795 | 0 | $0 |
| 2021 | AXON | 0 | $0 | 4,204 | $525,260 | 0 | $0 |
| 2020 | AXON | 0 | $0 | 2,993 | $360,476 | 0 | $0 |
| 2019 | AXON | 0 | $0 | 4,168 | $267,985 | 0 | $0 |
| 2018 | AXON | 0 | $0 | 10,197 | $527,455 | 0 | $0 |
| 2015 | AXON | 0 | $0 | 0 | $0 | 90,134 | $1,209,868 |
2. Axon Enterprise, Inc. (AXON)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-10 | HAE | Buy | 1,400 | 70.56 | 98,784 |
| 2022-08-15 | HAE | Sale | 8,016 | 73.71 | 590,859 |
| 2021-05-26 | HAE | Sale | 11,813 | 55.10 | 650,896 |
| 2021-05-26 | HAE | Option Ex | 10,353 | 35.50 | 367,562 |
| 2020-04-09 | HAE | Option Ex | 6,573 | 45.45 | 298,742 |
| 2020-04-09 | HAE | Sale | 10,902 | 102.00 | 1,112,004 |
| 2018-11-07 | HAE | Option Ex | 8,196 | 36.37 | 298,088 |
| 2018-11-07 | HAE | Sale | 10,707 | 114.00 | 1,220,598 |
| 2018-01-02 | HAE | Sale | 7,118 | 63.00 | 448,434 |
| 2018-01-02 | HAE | Option Ex | 7,118 | 34.41 | 244,894 |
| 2017-05-15 | HAE | Option Ex | 8,580 | 27.24 | 233,719 |
| 2017-05-15 | HAE | Sale | 8,580 | 41.49 | 355,992 |
| 2015-02-27 | HAE | Sale | 11,328 | 44.80 | 507,483 |
| 2015-02-27 | HAE | Option Ex | 11,328 | 29.23 | 331,117 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-07 | AXON | Sale | 3,549 | 220.79 | 783,573 |
| 2022-06-08 | AXON | Sale | 3,159 | 102.82 | 324,795 |
| 2021-05-12 | AXON | Sale | 4,204 | 124.94 | 525,260 |
| 2020-11-16 | AAXN | Sale | 2,993 | 120.44 | 360,476 |
| 2019-11-13 | AAXN | Sale | 4,168 | 64.30 | 267,985 |
| 2018-08-20 | AAXN | Sale | 7,097 | 64.34 | 456,620 |
| 2014-12-16 | AAXN | Sale | 3,100 | 22.85 | 70,835 |
| 2015-05-08 | TASR | Option Ex | 90,134 | 13.42 | 1,209,868 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kroll Mark W (Director of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.